References

  1. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabtes mellitus: a randomised prospective 6 - year study. Diabetes Research and Clinical Practice. 1995; 28(2): 103-17. PubMed | Google Scholar

  2. UKPDS. Intensive bloood-glucose control with sulphonyureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet. 1998 (352): 837-53. PubMed | Google Scholar

  3. WHO. Adherence to long-term therapies: Evidence for action 2003. Accessed on 14 November 2016.

  4. Khattab M, Yousef K, Abdelkarim A, Karim A. Factors associated with poor glycemic control among patients with Type 2 daibetes. Journal of Diabetes and Its Complications. 2010; 24(2): 84-9. PubMed | Google Scholar

  5. Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. North American Journal of Medical Science. 2011 Sep; 3(9): 418-23. PubMed | Google Scholar

  6. Balkrishnan R. Predictors of medication adherence in the elderly. Clinical Therapeutics. 1998; 20(4): 764-71. PubMed | Google Scholar

  7. Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine. 2005; 353(5): 487-97. PubMed | Google Scholar

  8. IDF. IDF Diabetes Atlas 7th edition. 2015; pp70-7. Accessed on 22 November 2016.

  9. MOH. Kenya National Diabetes Strategy 2010-2015. Accessed on 22 November 2016.

  10. Dirk L, Henrik F, Mwaniki D, Kilonzo B, Tetens I, Boit M. Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Research and Clinical Practice. 2009; 84(3): 303-10. PubMed | Google Scholar

  11. Otieno C, Vaghela V, Mwendwa F, Kayima J, Ogola E. Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the out patient diabetic clinic of Kenyatta National Hospital, Nairobi. East Africa Medical Journal. 2005; 82(12 Suppl): 184-90. PubMed | Google Scholar

  12. Mwendwa F, Otieno C, Kayima J, Amayo E, Otieno P. Risk factor profile and the occurrence of micro-vascular complications on short term type 2 diabetes mellitus at Kenyatta National Hospital Nairobi. East Africa Medical Journal. 2005; 82(12 Suppl): 163-72. PubMed | Google Scholar

  13. Gorstein J, Sullivan K, Parvanta I, Begin F. Indicators and methods for cross-sectional surveys of vitamin and mineral status of populations. Micronutrient Initiative, Centers for Disease Control. 2007; 35. Google Scholar

  14. Shobhana R, Begum R, Snehalatha C, Vijay V, Ramachandran A. Patient adherence to diabetes treatment. Journal of Association of Physicians of India. 1999; 47(12): 1173-5. PubMed | Google Scholar

  15. Morisky D, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication Adherence Measure for Hypertension Control. Journal of Clinical Hypertension. 2008; 10(5): 348-54. PubMed | Google Scholar

  16. Krousel-Wood M, Islam T, Webber L, Re R, Morisky D. New Medication Adherence Scale Versus Pharmacy Fill Rates in Seniors With Hypertension. American Journal of Managed Care. 2009; 15(1): 59-66. PubMed | Google Scholar

  17. Al-Qazaz H, Hassali M, Shafie A, Sundram S, Morisky D. The Eight-Item Morisky Medication Adherence Scale (MMAS-08): translation and Validation of the Malaysian version. Diabetes Research and Clinical Practice. 2010; 90(2): 216-21. Google Scholar

  18. Ewing J. Detecting Alcoholism: The CAGE Questionaire. Journal of American Medical Association. 1984; 252(14): 1905-7. PubMed | Google Scholar

  19. WHO. Obesity preventing and managing the global epidemic. Report of a WHO consultation on obesity. 1998; Accessed on 22 November 2016.

  20. Abebe S, Berhane Y, Worku A. Barriers to diabetes medication adherence in North West Ethiopia. SpringerPlus. 2014; 3: 195. PubMed | Google Scholar

  21. Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Journal of Drug, Healthcare and Patient Safety. 2014; 6: 155-65. PubMed | Google Scholar

  22. MOH. KENYA STEPwise Survey For Non Communicable Diseases Risk Factors: 2015 Report. Nairobi: Ministry of Health. 2015. Google Scholar

  23. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications: a systematic review. BMC Public Health. 2011; 11: 564. PubMed | Google Scholar

  24. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine. 2006 Sep 25; 166(17): 1836-41. PubMed | Google Scholar

  25. MOPHS. National Clinical Guidelines for management of Diabetes Mellitus. Nairobi: Government of Kenya. 2010. Google Scholar

  26. Mwavua SM, Ndungu EK, Mutai KK, Joshi MD. A comparative study of the quality of care and glycemic control among ambulatory type 2 diabetes mellitus clients, at a Tertiary Referral Hospital and a Regional Hospital in Central Kenya. BMC Research Notes. 2016; 9: 12. PubMed | Google Scholar

  27. Odume BB, Ofoegbu OS, Aniwada EC, Okechukwu EF. The influence of family characteristics on glycaemic control among adult patients with type 2 diabetes mellitus attending the general outpatient clinic, National Hospital, Abuja, Nigeria. South African Family Practice. 2015; 57(6): 347-52. Google Scholar

  28. WHO. Diabetes Factsheet. Updated November 2017. Accessed on 22 November 2016.

  29. Stubbs B, Micek M, Pfeiffer J, Montoya P, Gloyd S. Treatment partners and adherence to HAART in Central Mozambique. AIDS Care. 2009 Nov; 21(11): 1412-9. PubMed | Google Scholar

  30. Wandwalo E, Kapalata N, Egwaga S, Morkve O. Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. International Journal of Tuberculosis and Lung Diseases. 2004 Oct; 8(10): 1248-54. PubMed | Google Scholar

  31. Ayah R, Joshi MD, Wanjiru R, Njau EK, Otieno CF, Njeru EK et al. A population-based survey of prevalence of diabetes and correlates in an urban slum community in Nairobi, Kenya. BMC Public Health. 2013; 13: 371. PubMed | Google Scholar

  32. Rwegerera GM. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania: a cross-sectional study. The Pan African Medical Journal. 2014; 17: 252. PubMed | Google Scholar

  33. Tiv M, Viel J, Mauny F, Eschwege E, Weill A, Fournier C et al. Medication Adherence in Type 2 Diabetes: the ENTRED Study 2007, a French Population-Based Study. PLOS ONE. 2012; 7(3): e32412. PubMed | Google Scholar

  34. Kalyango J, Owino E, Nambuya A. Non-adherence to diabetic treatment at Mulago Hospital in Uganda: prevalence and associated factors. African Health Sciences. 2008; 8(2): 67-73. PubMed | Google Scholar

  35. Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH et al. Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database. Diabetes Care. 2015 Apr; 38(4): 604-9. PubMed | Google Scholar

  36. Awodele O, Osuolale JA. Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria. African Health Sciences. 2015 Jun; 15(2): 513-22. PubMed | Google Scholar

  37. Bagonza J, Rutebemberwa E, Bazeyo W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross-sectional study. BMC Health Service Research. 2015 Apr 19; 15: 168. PubMed | Google Scholar

  38. Borgsteede SD, Westerman MJ, Kok IL, Meeuse JC, de Vries TP, Hugtenburg JG. Factors related to high and low levels of drug adherence according to patients with type 2 diabetes. International Journal of Clinical Pharmacy. 2011 Oct; 33(5): 779-87. PubMed | Google Scholar

  39. Ahmed AT, Karter AJ, Liu J. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabetic Medicine. 2006 July; 23(7): 795-802. PubMed | Google Scholar

  40. Wambui CK, Kumar AM, Hinderaker SG, Chinnakali P, Pastakia SD, Kamano J. Do diabetes mellitus patients adhere to self-monitoring of blood glucose(SMBG) and is this associated with glycemic control: experience from a SMBG program in western Kenya. Diabetes Research and Clinical Practice. 2015; 112: 37-43. PubMed | Google Scholar

  41. Ijeoma LO, Ekpemiro JN, Okwor EU, Okpala PU, Adeyemo FO. Economic burden and catastrophic cost among people living with type 2 diabetes mellitus attending a tertiary health institution in South-East zone, Nigeria. BMC Research Notes 2015; 8: 527. Google Scholar

  42. MOH. 2013 Kenya Household Health Expenditure and Utilisation Survey. Nairobi: Ministry of Health. 2014. Google Scholar

  43. Ciechanowski P, Katon W, Russo J, Walker E. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. American Journal of Psychiatry. 2001 Jan; 158(1) 29-35. PubMed | Google Scholar